{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:06:26Z","timestamp":1747454786956,"version":"3.40.5"},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Fabry disease (FD) is an X-linked lysosomal storage disease caused by \u03b1-galactosidase A deficiency, leading to intralysosomal build-up of glycosphingolipids. In this case report, a 35-year-old male presented with thousands of angiokeratomas, primarily concentrated in the \u201cbathing-trunk\u201d area. Despite numerous visits to doctors in different specialities FD was not suspected. Enzyme replacement therapy effectively halted symptom progression. We recommend that patients with angiokeratomas and\/or symptoms from other organs indicative of FD should undergo further genetic examination.<\/jats:p>","DOI":"10.61409\/v03240232","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T14:09:06Z","timestamp":1730902146000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["Angiokeratomas in a patient with Fabry disease"],"prefix":"10.61409","author":[{"given":"Rami","family":"Nabil Al-Chaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer Valdemar","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004;337(2):319-335. https:\/\/doi.org\/10.1016\/j.jmb.2004.01.035","DOI":"10.1016\/j.jmb.2004.01.035"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Germain DP, Levade T, Hachulla E et al. Challenging the traditional approach for interpreting genetic variants: lessons from Fabry disease. Clin Genet. 2022;101(4):390. https:\/\/doi.org\/10.1111\/cge.14102","DOI":"10.1111\/cge.14102"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Orteu CH, Jansen T, Lidove O et al. Fabry disease and the skin: data from FOS, the Fabry outcome survey. Br J Dermatol. 2007;157(2):331-337. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08002.x","DOI":"10.1111\/j.1365-2133.2007.08002.x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Effraimidis G, Rasmussen \u00c5K, Dunoe M et al. Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience. PLoS One. 2022;17(11):1-18. https:\/\/doi.org\/10.1371\/journal.pone.0277767","DOI":"10.1371\/journal.pone.0277767"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Hopkin RJ, Cabrera GH, Jefferies JL et al. Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry. Mol Genet Metab. 2022;138(2):106967-106967. https:\/\/doi.org\/10.1016\/j.ymgme.2022.106967","DOI":"10.1016\/j.ymgme.2022.106967"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T11:25:29Z","timestamp":1747394729000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V03240232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v03240232","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}